On the pre-conference day on BioPharma Asia Convention 2013, Mr Angelos Dovletoglou, Executive Director, Preclinical Development Sciences of Epizyme was one of the distinguished speaker at the Preclinical World Asia.
Dr. Angelos is responsible for all preclinical development activities at Epizyme, including CMC, DMPK/ADME, toxicology, quality, supply chain and regulatory affairs. He leads Epizyme's preclinical development activities conducted through external CMOs and CROs, collaborations and partnerships in Asia.
In his talk on the topic “Optimizing the productivity of your preclinical model for efficient drug R&D process”, he gave a case study that outlined the initiation and evolution of chemistry outsourcing and also seamless transition to preclinical and clinical development.
Find out what you missed and join us at BioPharma Asia Convention 2014! More details can be found at the website